BioSpace News Archive

Tarsus Pharmaceuticals, Inc. today announced financial results for the third quarter ended September 30, 2022, and recent business achievements.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced a poster presentation by an academic collaborator at Neuroscience 2022 by the Society for Neuroscience being held November 12-16, 2022, at the San Diego Convention Center in San Diego, Calif.

Clearside Biomedical, Inc. announced today positive results from its OASIS Phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) administered by suprachoroidal injection via Clearside’s SCS Microinjector® in neovascular age-related macular degeneration (wet AMD) patients.

Kernal Biologics, Inc. today announced it will have three presentations at the International mRNA Health Conference being held in Boston and virtually from November 8th to 10th, 2022.

Ionis Pharmaceuticals, Inc. reported financial results for the third quarter of 2022.

Ipsen announced the Phase III NAPOLI 3 trial of Onivyde® plus 5 fluorouracil/leucovorin and oxaliplatin met its primary endpoint demonstrating clinically meaningful and statistically significant improvement in overall survival compared to nab-paclitaxel plus gemcitabine in 770 previously untreated patients with metastatic pancreatic ductal adenocarcinoma and key secondary efficacy outcome of progression-free survival also showed significant improvement over the comparator arm.

Sosei Group Corporation announces its President & CEO Chris Cargill and Matt Barnes, Head of UK R&D, will participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference on Tuesday, 15 November at 11:30 a.m. GMT / 6:30 a.m. ET / 8:30 p.m. JST.

Oblique Therapeutics AB, a biotechnology company focused on new antibody medicines for severe diseases with large unmet medical needs, is pleased to announce the confirmation of Christer Nordstedt MD.PhD. as Chief Executive Officer.

NanoString Technologies, Inc. and Abcam announced the expansion of their long-standing relationship with a new agreement to co-market Abcam antibodies for NanoString’s high-plex spatial multiomic solutions.

Sage Therapeutics, Inc. announced that the Company will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022, at 10:55 a.m. ET in New York, NY.